Clinical Trials Browser

Not yet recruiting × INDUSTRY × Hydroxyurea × Clear all

NCT07170592 2026-04-07

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients

Phase 1 Not yet recruiting

Other solid neoplasm

Treatment-Refractory Solid Tumors